Bradley A Schulte Selected Research

Neoplasm Metastasis (Metastasis)

12/2017

MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bradley A Schulte Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 01/2006
4	Lung Neoplasms (Lung Cancer) 09/2017 - 01/2013
2	Triple Negative Breast Neoplasms 01/2021 - 12/2017
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Hearing Loss (Hearing Impairment) 01/2018
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Residual Neoplasm 12/2017
1	Carcinogenesis 09/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017
1	Auditory neuropathy 06/2008
1	Noise-Induced Hearing Loss (Acoustic Trauma) 03/2006
1	Bartter Syndrome (Syndrome, Bartter) 03/2006
1	Deafness (Deaf Mutism) 03/2006
1	Rhinosinusitis 01/2005
1	Cystic Fibrosis (Mucoviscidosis) 01/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2005
1	Dehydration (Water Stress) 01/2005
1	Mucocele 01/2005
1	Allergic Fungal Sinusitis 01/2005
1	Cerebrospinal Fluid Leak 01/2005
1	Atrophy 03/2003
1	Necrosis 12/2002
1	Edema (Dropsy) 10/2002

Drug/Important Bio-Agent (IBA)

2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2013
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 01/2013
2	ResveratrolIBA 12/2013 - 01/2013
1	AntioxidantsIBA 01/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2019
1	CytokinesIBA 12/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Biological ProductsIBA 12/2017
1	triptolideIBA 12/2017
1	MicroRNAs (MicroRNA)IBA 09/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2015
1	MTOR InhibitorsIBA 01/2015
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2015
1	TOR Serine-Threonine KinasesIBA 01/2015
1	Cysteine (L-Cysteine)FDA Link 12/2013
1	GalactosidasesIBA 12/2013
1	nutlin 3IBA 08/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	NF-kappa B (NF-kB)IBA 03/2006
1	SaltsIBA 03/2006
1	Protein Isoforms (Isoforms)IBA 03/2006
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2005
1	hexacyanoferrate II (ferrocyanide)IBA 01/2005
1	thiocarbohydrazideIBA 01/2005
1	Oxygen (Dioxygen)IBA 01/2005
1	Osmium TetroxideIBA 01/2005
1	Surface-Active Agents (Surfactants)IBA 01/2005
1	MucinsIBA 01/2005
1	Cell Surface ReceptorsIBA 03/2003
1	Dystroglycans (Dystroglycan)IBA 03/2003
1	Laminin (Merosin)IBA 12/2002
1	Adenosine Triphosphatases (ATPase)IBA 10/2002

Therapy/Procedure

4	Radiotherapy 09/2017 - 01/2006
3	Therapeutics 01/2021 - 12/2017
2	Drug Therapy (Chemotherapy) 12/2013 - 01/2006
1	Immunotherapy 12/2018
1	Transplantation 06/2008